BiG Research Alpha Idea: Sanofi
Sanofi produces pharmaceuticals and vaccines. The prescription drugs segment
represented 27.8% of sales in 2017, vaccines accounted for 14.6%, rare diseases
represented 8%, diabetes 18.2% and general consumption pharmaceuticals 13.8%. This
last segment includes pharmaceuticals for the treatment of allergies and colds, pain
relief and nutrition. In geographical terms, Sanofi is well diversified with 33% of sales in
the USA, 28% in Emerging Markets, 26% in West Europe and 13% in the Rest of the
World.
Sanofi is an integrated, global healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. Two segments make up Co.'s business: Pharmaceuticals and Vaccines. The Pharmaceuticals segment covers research, development, production and marketing of medicines, consisting of flagship products, plus a broad range of prescription medicines, generic medicines, and consumer health products. The Vaccines segment includes research, development, production and marketing of vaccines in five areas: pediatric vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines.
Banco de Investimento Global, S.A. (BiG) is a privately-held, specialized financial institution, with headquarters in Lisbon, and is licensed to operate in all business areas open to the banking sector in Portugal.
BiG Research specializes in finding long term investment ideas in European and US markets.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.